Hepatology

Filter

WHO Steatotic Liver Disease Resolution Marks Global Policy Shift

May 2026

The World Health Assembly has formally recognised liver disease within the global NCD agenda, prompting calls for national action and accountability.

WHO Steatotic Liver Disease Resolution Marks Global Policy Shift

The World Health Assembly has formally recognised liver disease within the global NCD agenda, prompting calls for national action and accountability.

Review of the European Association for the Study of the Liver (EASL) Congress 2025

THIS YEAR, the vibrant city of Amsterdam, the Netherlands played host to the European Association for the Study of the…

Phosphatidylethanol in Steatotic Liver Disease: EASL Congress 2025

ACCURATELY discerning the contribution of alcohol intake to the pathogenesis of steatotic liver disease (SLD) is fundamental to it…

MASH Redefined: Insights from the EASL Congress 2025

THE EUROPEAN Association for the Study of the Liver (EASL) Congress 2025, Amsterdam, the Netherlands, placed patients and…

Albumin Therapy for Decompensated Cirrhosis: EASL Congress 2025

THE MANAGEMENT of decompensated cirrhosis remains a formidable challenge in hepatology, owing to its multifaceted complications…

Pregnancy and Liver Disease: A Multidisciplinary Challenge

AT THIS year’s European Association for the Study of the Liver (EASL) Congress 2025, held in Amsterdam, the Netherlands…

EASL Congress 2025 Interview: Aleksander Krag

What we set out to do, and what we’ve continued working on, is exploring all the ways we could create the best possible Congress…

EASL Congress 2025 Interview: Debbie Shawcross

It always takes a village to organise an event the size of the EASL Congress. We had close to 8,000 registrants, so it was a huge…

Loading posts...